Edesa Biotech, Inc. (EDSA) financial statements (2021 and earlier)

Company profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
8/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6710711914
Cash and cash equivalents67457413
Short-term investments  62450
Receivables0000000
Inventory, net of allowances, customer advances and progress billings  0001 
Inventory  0001 
Prepaid expense1 00000
Other undisclosed current assets 1     
Total current assets:88117121014
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0011110
Long-term investments and receivables  000  
Long-term investments  000  
Intangible assets, net (including goodwill)22     
Intangible assets, net (excluding goodwill)22     
Deposits noncurrent assets  00000
Total noncurrent assets:3311110
TOTAL ASSETS:1011128131014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1100111
Other undisclosed accounts payable and accrued liabilities1100111
Debt 0     
Deferred revenue and credits  00
Other undisclosed current liabilities0    21
Total current liabilities:1200121
Noncurrent Liabilities
Long-term debt and lease obligation00     
Operating lease, liability00
Liabilities, other than long-term debt00     
Accounts payable and accrued liabilities00     
Other undisclosed noncurrent liabilities      5
Total noncurrent liabilities:00    5
Total liabilities:1200127
Stockholders' equity
Stockholders' equity attributable to parent, including:871171288
Common stock22195748473836
Additional paid in capital22     
Accumulated other comprehensive loss(0)(0)     
Accumulated deficit(16)(13)(50)(45)(40)(35)(34)
Other undisclosed stockholders' equity attributable to parent  54555
Other undisclosed stockholders' equity12     
Total stockholders' equity:991171288
TOTAL LIABILITIES AND EQUITY:1011128131014

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
8/31/2014
Revenues0000110
Revenue, net0110
Cost of revenue(0)(0)(0)(0)(0)(1)(1)
Cost of goods and services sold     (1)(1)
Other cost of operating revenue  (0)(0)(0)(0) 
Gross profit:00(0)(0)1(0)(1)
Operating expenses(8)(7)(5)(5)(6)(5)(6)
Other undisclosed operating income00000  
Operating loss:(8)(6)(5)(5)(5)(5)(7)
Nonoperating income (expense)0000(0)2(3)
Investment income, nonoperating0000000
Foreign currency transaction gain (loss), before tax(0)(0)(0)00(1)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes     11
Loss from continuing operations before income taxes:(8)(6)(5)(5)(5)(3)(8)
Income tax expense (0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(8)(6)(5)(5)(5)(3)(8)

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
8/31/2014
Net loss:(8)(6)(5)(5)(5)(3)(8)
Comprehensive loss:(8)(6)(5)(5)(5)(3)(8)
Other undisclosed comprehensive income, net of tax, attributable to parent00     
Comprehensive loss, net of tax, attributable to parent:(8)(6)(5)(5)(5)(3)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: